Specifically, the rebleeding group exhibited significantly higher heart rates, GBS scores, AIMS65 scores, CRP levels, TT, PT, and INR, alongside lower systolic blood pressure, hemoglobin, platelet count, albumin, and fibrinogen. This evidence concerns the gene CRP and Guillain-Barre syndrome.